Identification and characterization of key kinetic intermediates in amyloid beta-protein fibrillogenesis.

Amyloid beta -protein (Abeta) assembly: Abeta 40 and Abeta 42 oligomerize through distinct pathways. Proc Natl Acad Sci U S A (2002) 5.46

Stabilities and conformations of Alzheimer's beta -amyloid peptide oligomers (Abeta 16-22, Abeta 16-35, and Abeta 10-35): Sequence effects. Proc Natl Acad Sci U S A (2002) 3.06

On the nucleation of amyloid beta-protein monomer folding. Protein Sci (2005) 2.47

The Alzheimer's peptides Abeta40 and 42 adopt distinct conformations in water: a combined MD / NMR study. J Mol Biol (2007) 2.35

The role of microglia in amyloid clearance from the AD brain. J Neural Transm (Vienna) (2010) 2.21

Amyloid beta-protein monomer structure: a computational and experimental study. Protein Sci (2006) 1.99

Inhibitors of amyloid toxicity based on beta-sheet packing of Abeta40 and Abeta42. Biochemistry (2006) 1.88

Direct detection of transient alpha-helical states in islet amyloid polypeptide. Protein Sci (2006) 1.74

Molecular dynamics simulation of amyloid beta dimer formation. Biophys J (2004) 1.63

Amyloid beta-protein monomer folding: free-energy surfaces reveal alloform-specific differences. J Mol Biol (2008) 1.62

Critical nucleus size for disease-related polyglutamine aggregation is repeat-length dependent. Nat Struct Mol Biol (2011) 1.60

Helix stabilization precedes aqueous and bilayer-catalyzed fiber formation in islet amyloid polypeptide. J Mol Biol (2009) 1.53

Kinetic control of dimer structure formation in amyloid fibrillogenesis. Proc Natl Acad Sci U S A (2004) 1.52

A partially folded structure of amyloid-beta(1-40) in an aqueous environment. Biochem Biophys Res Commun (2011) 1.51

Structure of the 21-30 fragment of amyloid beta-protein. Protein Sci (2006) 1.51

The significance of the cholinergic system in the brain during aging and in Alzheimer's disease. J Neural Transm (Vienna) (2006) 1.50

A role for helical intermediates in amyloid formation by natively unfolded polypeptides? Phys Biol (2009) 1.49

Mechanisms of protein fibril formation: nucleated polymerization with competing off-pathway aggregation. Biophys J (2007) 1.48

Membrane disruption and early events in the aggregation of the diabetes related peptide IAPP from a molecular perspective. Acc Chem Res (2011) 1.46

Linking folding with aggregation in Alzheimer's beta-amyloid peptides. Proc Natl Acad Sci U S A (2007) 1.42

A critical assessment of the role of helical intermediates in amyloid formation by natively unfolded proteins and polypeptides. Protein Eng Des Sel (2009) 1.38

Design of small molecules that target metal-A{beta} species and regulate metal-induced A{beta} aggregation and neurotoxicity. Proc Natl Acad Sci U S A (2010) 1.37

Aqueous urea solution destabilizes Abeta(16-22) oligomers. Proc Natl Acad Sci U S A (2004) 1.34

Short peptide amyloid organization: stabilities and conformations of the islet amyloid peptide NFGAIL. Biophys J (2003) 1.33

Conformational transition of amyloid beta-peptide. Proc Natl Acad Sci U S A (2005) 1.28

Mechanism of islet amyloid polypeptide fibrillation at lipid interfaces studied by infrared reflection absorption spectroscopy. Biophys J (2007) 1.27

Structure and dynamics of parallel beta-sheets, hydrophobic core, and loops in Alzheimer's A beta fibrils. Biophys J (2007) 1.26

Structure-function relationships of pre-fibrillar protein assemblies in Alzheimer's disease and related disorders. Curr Alzheimer Res (2008) 1.26

Amyloid fibril formation can proceed from different conformations of a partially unfolded protein. Biophys J (2005) 1.25

CSF amyloid-beta-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia. Brain (2006) 1.25

NMR-detected hydrogen exchange and molecular dynamics simulations provide structural insight into fibril formation of prion protein fragment 106-126. Proc Natl Acad Sci U S A (2003) 1.22

Mechanism of IAPP amyloid fibril formation involves an intermediate with a transient β-sheet. Proc Natl Acad Sci U S A (2013) 1.20

Charge states rather than propensity for beta-structure determine enhanced fibrillogenesis in wild-type Alzheimer's beta-amyloid peptide compared to E22Q Dutch mutant. Protein Sci (2002) 1.19

Slow amyloid nucleation via α-helix-rich oligomeric intermediates in short polyglutamine-containing huntingtin fragments. J Mol Biol (2011) 1.17

Simultaneous single-molecule fluorescence and conductivity studies reveal distinct classes of Abeta species on lipid bilayers. Biochemistry (2010) 1.13

Amyloid fibrils of glucagon characterized by high-resolution atomic force microscopy. Biophys J (2006) 1.12

Nanofluidic biosensing for beta-amyloid detection using surface enhanced Raman spectroscopy. Nano Lett (2008) 1.11

Alternative pathways of human islet amyloid polypeptide aggregation distinguished by (19)f nuclear magnetic resonance-detected kinetics of monomer consumption. Biochemistry (2012) 1.11

Extracellular phosphorylation of the amyloid β-peptide promotes formation of toxic aggregates during the pathogenesis of Alzheimer's disease. EMBO J (2011) 1.10

Amino acid position-specific contributions to amyloid beta-protein oligomerization. J Biol Chem (2009) 1.10

The culprit behind amyloid beta peptide related neurotoxicity in Alzheimer's disease: oligomer size or conformation? Alzheimers Res Ther (2010) 1.09

Hypoxia due to cardiac arrest induces a time-dependent increase in serum amyloid β levels in humans. PLoS One (2011) 1.09

Amyloidogenesis of natively unfolded proteins. Curr Alzheimer Res (2008) 1.08

Effects of the English (H6R) and Tottori (D7N) familial Alzheimer disease mutations on amyloid beta-protein assembly and toxicity. J Biol Chem (2010) 1.07

Peptide dimer structure in an Aβ(1-42) fibril visualized with cryo-EM. Proc Natl Acad Sci U S A (2015) 1.07

Binding of amyloid beta-peptide to ganglioside micelles is dependent on histidine-13. Biochem J (2006) 1.05

The fibrillogenic L178H variant of apolipoprotein A-I forms helical fibrils. J Lipid Res (2011) 1.05

Mechanism of fiber assembly: treatment of Aβ peptide aggregation with a coarse-grained united-residue force field. J Mol Biol (2010) 1.04

Combination of kinetically selected inhibitors in trans leads to highly effective inhibition of amyloid formation. J Am Chem Soc (2010) 1.04

Current perspectives on cardiac amyloidosis. Am J Physiol Heart Circ Physiol (2011) 1.04

Formation of amyloid fibrils from fully reduced hen egg white lysozyme. Protein Sci (2004) 1.03

Investigating how peptide length and a pathogenic mutation modify the structural ensemble of amyloid beta monomer. Biophys J (2012) 1.02

Interaction between amyloid-beta (1-42) peptide and phospholipid bilayers: a molecular dynamics study. Biophys J (2009) 1.02

Structures and free-energy landscapes of the wild type and mutants of the Abeta(21-30) peptide are determined by an interplay between intrapeptide electrostatic and hydrophobic interactions. J Mol Biol (2008) 1.01

Dimer formation enhances structural differences between amyloid β-protein (1-40) and (1-42): an explicit-solvent molecular dynamics study. PLoS One (2012) 1.01

Helical conformation of the SEVI precursor peptide PAP248-286, a dramatic enhancer of HIV infectivity, promotes lipid aggregation and fusion. Biophys J (2009) 1.00

Interpeptide interactions induce helix to strand structural transition in Abeta peptides. Proteins (2009) 0.99

Intermediacy of poly(L-proline) II and beta-strand conformations in poly(L-lysine) beta-sheet formation probed by temperature-jump/UV resonance Raman spectroscopy. Biochemistry (2006) 0.99

Unfolding, aggregation, and amyloid formation by the tetramerization domain from mutant p53 associated with lung cancer. Biochemistry (2006) 0.98

Impact of the mutation A21G (Flemish variant) on Alzheimer's beta-amyloid dimers by molecular dynamics simulations. Biophys J (2006) 0.96

A statistical-mechanical theory of fibril formation in dilute protein solutions. Biophys J (2006) 0.96

Structural differences between Abeta(1-40) intermediate oligomers and fibrils elucidated by proteolytic fragmentation and hydrogen/deuterium exchange. Biophys J (2009) 0.95

Stabilization of discordant helices in amyloid fibril-forming proteins. Protein Sci (2004) 0.95

The amyloidogenic SEVI precursor, PAP248-286, is highly unfolded in solution despite an underlying helical tendency. Biochim Biophys Acta (2011) 0.95

Role of aromatic interactions in amyloid formation by islet amyloid polypeptide. Biochemistry (2013) 0.93

Targeting intrinsically disordered proteins in neurodegenerative and protein dysfunction diseases: another illustration of the D(2) concept. Expert Rev Proteomics (2010) 0.93

Highly neurotoxic monomeric α-helical prion protein. Proc Natl Acad Sci U S A (2012) 0.92

Characterizing the assembly of the Sup35 yeast prion fragment, GNNQQNY: structural changes accompany a fiber-to-crystal switch. Biophys J (2010) 0.92

The stability and dynamics of the human calcitonin amyloid peptide DFNKF. Biophys J (2004) 0.92

Computational simulations of the early steps of protein aggregation. Prion (2007) 0.92

Regulation and aggregation of intrinsically disordered peptides. Proc Natl Acad Sci U S A (2015) 0.91

Structural basis for Aβ1–42 toxicity inhibition by Aβ C-terminal fragments: discrete molecular dynamics study. J Mol Biol (2011) 0.91

A two-site mechanism for the inhibition of IAPP amyloidogenesis by zinc. J Mol Biol (2011) 0.91

Chemical chaperone and inhibitor discovery: potential treatments for protein conformational diseases. Perspect Medicin Chem (2007) 0.90

A kinetic model for beta-amyloid adsorption at the air/solution interface and its implication to the beta-amyloid aggregation process. J Phys Chem B (2009) 0.90

Molecular structure of amyloid fibrils controls the relationship between fibrillar size and toxicity. PLoS One (2011) 0.89

A molecular dynamics study of the early stages of amyloid-beta(1-42) oligomerization: the role of lipid membranes. Proteins (2010) 0.89

Nanoprobing of the effect of Cu(2+) cations on misfolding, interaction and aggregation of amyloid β peptide. J Neuroimmune Pharmacol (2012) 0.89

Despite its role in assembly, methionine 35 is not necessary for amyloid beta-protein toxicity. J Neurochem (2010) 0.89

Tau binds to lipid membrane surfaces via short amphipathic helices located in its microtubule-binding repeats. Biophys J (2014) 0.89

Conformational pH dependence of intermediate states during oligomerization of the human prion protein. Protein Sci (2008) 0.88

Beta-barrel models of soluble amyloid beta oligomers and annular protofibrils. Proteins (2010) 0.88

Effect of the Tottori familial disease mutation (D7N) on the monomers and dimers of Aβ40 and Aβ42. ACS Chem Neurosci (2013) 0.88

Carvedilol as a potential novel agent for the treatment of Alzheimer's disease. Neurobiol Aging (2010) 0.88

The OPEP protein model: from single molecules, amyloid formation, crowding and hydrodynamics to DNA/RNA systems. Chem Soc Rev (2014) 0.88

Protein aggregation/folding: the role of deterministic singularities of sequence hydrophobicity as determined by nonlinear signal analysis of acylphosphatase and Abeta(1-40). Biophys J (2003) 0.88

Structural dynamics of the ΔE22 (Osaka) familial Alzheimer's disease-linked amyloid β-protein. Amyloid (2011) 0.87

Fibril elongation by Aβ(17-42): kinetic network analysis of hybrid-resolution molecular dynamics simulations. J Am Chem Soc (2014) 0.87

Heterologous amyloid seeding: revisiting the role of acetylcholinesterase in Alzheimer's disease. PLoS One (2007) 0.87

Polymorphism of β2-microglobulin amyloid fibrils manifested by ultrasonication-enhanced fibril formation in trifluoroethanol. J Biol Chem (2012) 0.87

A glycine zipper motif mediates the formation of toxic β-amyloid oligomers in vitro and in vivo. Mol Neurodegener (2011) 0.87

Aggregation and fibril morphology of the Arctic mutation of Alzheimer's Aβ peptide by CD, TEM, STEM and in situ AFM. J Struct Biol (2012) 0.86

Surfactant-induced conformational transition of amyloid beta-peptide. Eur Biophys J (2008) 0.86

Requirement of aggregation propensity of Alzheimer amyloid peptides for neuronal cell surface binding. BMC Neurosci (2007) 0.86

Targeting the proper amyloid-beta neuronal toxins: a path forward for Alzheimer's disease immunotherapeutics. Alzheimers Res Ther (2014) 0.86

A chemical analog of curcumin as an improved inhibitor of amyloid Abeta oligomerization. PLoS One (2012) 0.86

Mechanism of zinc(II)-promoted amyloid formation: zinc(II) binding facilitates the transition from the partially alpha-helical conformer to aggregates of amyloid beta protein(1-28). J Biol Inorg Chem (2008) 0.86

Keampferol-3-O-rhamnoside abrogates amyloid beta toxicity by modulating monomers and remodeling oligomers and fibrils to non-toxic aggregates. J Biomed Sci (2012) 0.84

A study of the α-helical intermediate preceding the aggregation of the amino-terminal fragment of the β amyloid peptide (Aβ(1-28)). J Phys Chem B (2011) 0.84

Intrinsic determinants of Aβ(12-24) pH-dependent self-assembly revealed by combined computational and experimental studies. PLoS One (2011) 0.83

Beta-secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science (1999) 13.19

A cellular gene encodes scrapie PrP 27-30 protein. Cell (1985) 8.86

Amyloid beta-peptide is produced by cultured cells during normal metabolism. Nature (1992) 7.16

The 'Arctic' APP mutation (E693G) causes Alzheimer's disease by enhanced Abeta protofibril formation. Nat Neurosci (2001) 5.29

Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate. J Biol Chem (1997) 5.07

On the nucleation and growth of amyloid beta-protein fibrils: detection of nuclei and quantitation of rate constants. Proc Natl Acad Sci U S A (1996) 4.75

Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates. J Biol Chem (1999) 4.64

Protofibrillar intermediates of amyloid beta-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons. J Neurosci (1999) 3.92

Homologies between signal transducing G proteins and ras gene products. Science (1984) 3.85

Structural studies of the scrapie prion protein using mass spectrometry and amino acid sequencing. Biochemistry (1993) 3.54

Kinetic theory of fibrillogenesis of amyloid beta-protein. Proc Natl Acad Sci U S A (1997) 3.40

Electroblotting onto activated glass. High efficiency preparation of proteins from analytical sodium dodecyl sulfate-polyacrylamide gels for direct sequence analysis. J Biol Chem (1986) 3.33

Truncated forms of the human prion protein in normal brain and in prion diseases. J Biol Chem (1995) 3.20

Small assemblies of unmodified amyloid beta-protein are the proximate neurotoxin in Alzheimer's disease. Neurobiol Aging (2004) 3.13

Neuronal development in the Drosophila retina: monoclonal antibodies as molecular probes. Cell (1984) 3.02

Amyloid beta-protein oligomerization: prenucleation interactions revealed by photo-induced cross-linking of unmodified proteins. J Biol Chem (2001) 2.77

Presenilin-dependent gamma-secretase processing of beta-amyloid precursor protein at a site corresponding to the S3 cleavage of Notch. EMBO Rep (2001) 2.70

Aggregation of secreted amyloid beta-protein into sodium dodecyl sulfate-stable oligomers in cell culture. J Biol Chem (1995) 2.68

Purification and properties of the cellular and scrapie hamster prion proteins. Eur J Biochem (1988) 2.35

Enhanced production and oligomerization of the 42-residue amyloid beta-protein by Chinese hamster ovary cells stably expressing mutant presenilins. J Biol Chem (1997) 2.33

Metabolism of the "Swedish" amyloid precursor protein variant in neuro2a (N2a) cells. Evidence that cleavage at the "beta-secretase" site occurs in the golgi apparatus. J Biol Chem (1996) 2.19

In silico study of amyloid beta-protein folding and oligomerization. Proc Natl Acad Sci U S A (2004) 2.13

Isolation and characterization of a cDNA clone for the gamma subunit of bovine retinal transducin. Proc Natl Acad Sci U S A (1984) 2.12

beta-Amyloid peptide and a 3-kDa fragment are derived by distinct cellular mechanisms. J Biol Chem (1993) 2.01

Cloning and characterization of the myelin basic protein gene from mouse: one gene can encode both 14 kd and 18.5 kd MBPs by alternate use of exons. Cell (1985) 1.98

Presenilin proteins undergo heterogeneous endoproteolysis between Thr291 and Ala299 and occur as stable N- and C-terminal fragments in normal and Alzheimer brain tissue. Neurobiol Dis (1997) 1.92

Generation of amyloid beta protein from its precursor is sequence specific. Neuron (1995) 1.82

Interaction of distinct domains in Mu transposase with Mu DNA ends and an internal transpositional enhancer. Nature (1989) 1.82

Temperature dependence of amyloid beta-protein fibrillization. Proc Natl Acad Sci U S A (1998) 1.78

The role of APP processing and trafficking pathways in the formation of amyloid beta-protein. Ann N Y Acad Sci (1996) 1.67

An improved method of preparing the amyloid beta-protein for fibrillogenesis and neurotoxicity experiments. Amyloid (2000) 1.56

Mutations associated with a locus for familial Alzheimer's disease result in alternative processing of amyloid beta-protein precursor. J Biol Chem (1994) 1.54

Oligomerization of endogenous and synthetic amyloid beta-protein at nanomolar levels in cell culture and stabilization of monomer by Congo red. Biochemistry (1998) 1.54

Primary structure of the human melanoma-associated antigen p97 (melanotransferrin) deduced from the mRNA sequence. Proc Natl Acad Sci U S A (1986) 1.46

A furin-like convertase mediates propeptide cleavage of BACE, the Alzheimer's beta -secretase. J Biol Chem (2000) 1.41

Sequence homology of the LFA-1 and Mac-1 leukocyte adhesion glycoproteins and unexpected relation to leukocyte interferon. Nature (1985) 1.39

Elucidation of amyloid beta-protein oligomerization mechanisms: discrete molecular dynamics study. J Am Chem Soc (2010) 1.38

Biosynthesis and membrane topography of the neural cell adhesion molecule L1. EMBO J (1985) 1.34

Gene regulatory factors of the sea urchin embryo. I. Purification by affinity chromatography and cloning of P3A2, a novel DNA-binding protein. Development (1991) 1.34

Monitoring protein assembly using quasielastic light scattering spectroscopy. Methods Enzymol (1999) 1.32

Excessive production of amyloid beta-protein by peripheral cells of symptomatic and presymptomatic patients carrying the Swedish familial Alzheimer disease mutation. Proc Natl Acad Sci U S A (1994) 1.31

A de novo designed helix-turn-helix peptide forms nontoxic amyloid fibrils. Nat Struct Biol (2000) 1.31

Partial N-terminal amino acid sequences of three nonstructural proteins of two flaviviruses. Virology (1986) 1.31

Structural domains in phage Mu transposase: identification of the site-specific DNA-binding domain. Proc Natl Acad Sci U S A (1987) 1.29

Identification of the active site tyrosine of Flp recombinase. Possible relevance of its location to the mechanism of recombination. J Biol Chem (1990) 1.27

Role of electrostatic interactions in amyloid beta-protein (A beta) oligomer formation: a discrete molecular dynamics study. Biophys J (2007) 1.22

Identification of cDNA clones of the mouse neural cell adhesion molecule L1. Neurosci Lett (1987) 1.18

Cloning and characterization of cDNA encoding canine alpha-L-iduronidase. mRNA deficiency in mucopolysaccharidosis I dog. J Biol Chem (1992) 1.15

Polarized secretion of beta-amyloid precursor protein and amyloid beta-peptide in MDCK cells. Proc Natl Acad Sci U S A (1994) 1.12

Ecomycins, unique antimycotics from Pseudomonas viridiflava. J Appl Microbiol (1998) 1.10

Cryptocandin, a potent antimycotic from the endophytic fungus Cryptosporiopsis cf. quercina. Microbiology (1999) 1.09

Effects of the Arctic (E22-->G) mutation on amyloid beta-protein folding: discrete molecular dynamics study. J Am Chem Soc (2008) 1.09

Pseudomycins, a family of novel peptides from Pseudomonas syringae possessing broad-spectrum antifungal activity. J Gen Microbiol (1991) 1.09

Polarized sorting of beta-amyloid precursor protein and its proteolytic products in MDCK cells is regulated by two independent signals. J Cell Biol (1995) 1.07

In vitro studies of amyloid beta-protein fibril assembly and toxicity provide clues to the aetiology of Flemish variant (Ala692-->Gly) Alzheimer's disease. Biochem J (2001) 1.06

Identification of cellular proteins binding to the scrapie prion protein. Biochemistry (1990) 1.06

beta-Amyloid, protein processing and Alzheimer's disease. Arzneimittelforschung (1995) 1.02

Normal cellular processing of the beta-amyloid precursor protein results in the secretion of the amyloid beta peptide and related molecules. Ann N Y Acad Sci (1993) 1.02

Degradation of amyloid beta-protein by a serine protease-alpha2-macroglobulin complex. J Biol Chem (1996) 1.00

The vacuolar H(+)-ATPase inhibitor bafilomycin A1 differentially affects proteolytic processing of mutant and wild-type beta-amyloid precursor protein. J Biol Chem (1995) 0.98

A new peptide in the FMRFamide family isolated from the CNS of the hawkmoth, Manduca sexta. Peptides (1990) 0.98

Separation of presenilin function in amyloid beta-peptide generation and endoproteolysis of Notch. Proc Natl Acad Sci U S A (2000) 0.96

Microscale structure analysis of a high-molecular-weight, hydrophobic membrane glycoprotein fraction with platelet-derived growth factor-dependent kinase activity. J Chromatogr (1986) 0.95

Effects of the amyloid precursor protein Glu693-->Gln 'Dutch' mutation on the production and stability of amyloid beta-protein. Biochem J (1999) 0.95

Lysosomal processing of amyloid precursor protein to A beta peptides: a distinct role for cathepsin S. Biochem J (1995) 0.94

Metabolism of the "Swedish" amyloid precursor protein variant in Madin-Darby canine kidney cells. J Biol Chem (1994) 0.94

Differential effect of phosphorylation and substrate modulation on tau's ability to promote microtubule growth and nucleation. J Biol Chem (1994) 0.93

Inhibition of amyloid beta-protein production in neural cells by the serine protease inhibitor AEBSF. Neuron (1996) 0.93

High performance liquid chromatographic separation of the globin chains of non-human hemoglobins. Hemoglobin (1985) 0.92

Domain of a yeast site-specific recombinase (Flp) that recognizes its target site. Proc Natl Acad Sci U S A (1991) 0.90

Dynamics of metastable β-hairpin structures in the folding nucleus of amyloid β-protein. J Phys Chem B (2012) 0.87

In vitro phosphorylation of mouse osteopontin expressed in E. coli. Biochem Biophys Res Commun (1993) 0.84

Identification of a peptide fragment from the carboxyl-terminal extension region (E-domain) of rat proinsulin-like growth factor-II. J Biol Chem (1985) 0.83

A partial genomic DNA clone for the alpha subunit of the mouse complement receptor type 3 and cellular adhesion molecule Mac-1. Proc Natl Acad Sci U S A (1986) 0.81

Antibodies to amyloid beta protein (A beta) crossreact with glyceraldehyde-3-phosphate dehydrogenase (GAPDH). Neurobiol Aging (1996) 0.79

Identity of PSA purified from seminal fluid by different methods: comparison by amino acid analysis and assigned extinction coefficients. Prostate (1995) 0.79

Imaging as a tool for improving length and accuracy of sequence analysis in automated fluorescence-based DNA sequencing. Electrophoresis (1991) 0.78

Phylogenetically conserved amino acids of MBP and P0 from amphibian myelin. J Mol Neurosci (1992) 0.76

Unusual phylogenetic conservation of the N-terminal amino acid sequence of the central nervous system-specific membrane glycoprotein F3-87-8 (CNSgp130). J Neurochem (1986) 0.75

New instrumentation facilitates the study of genes coding for molecules involved in cell surface recognition. Adv Exp Med Biol (1984) 0.75

Synthesis and characterization of a bioactive 82-residue sphingolipid activator protein, saposin C. J Mol Neurosci (1993) 0.75

Generation of DM-20 splice site in myelin proteolipid protein gene: a hypothesis based on analysis of the amphibian protein. Pept Res (1992) 0.75